Nurosene proposes NetraMark acquisition

Latest articles

Exclusive: “Mitlets” hold potential for mitochondria transfusion

Mitrix Bio believes recently discovered blood components may support transfusion of large quantities of healthy mitochondria from donor to patient. Earlier this year, we brought...

Optimise your body and mind by tackling cell stress

Want to live longer and heathier? Combating cell stress is an important first step on your longevity journey. It's a fast-paced, busy world, and we're...

Crypto – pulling a (Moon) Rabbit out a hat for longevity

Angel Versetti on why it makes sense to look at more experimental solutions for longevity. Earlier this week we brought you part one of our...

New webinar will explore the opportunity of ovarian longevity

What does delaying menopause mean in terms of investment activity, societal change and the technologies that will reshape the lives of multiple millions of...

Most read

New supplement slows aging and promotes weight loss

Sugar-proof your way to a longer life. Reducing AGEs to slow aging and increase weight loss – how one supplement is fighting the war...

An antiaging supplement that also reduces appetite?

One for the AGEs: Juvify signs IP licensing deal with Buck Institute for GLYLO antiaging supplement that aims to reduce glycation. A researcher at the...

Resveratrol – the small molecule with big antiaging ideas

When it comes to antiaging molecules, we can learn a thing or two from plants. As so often in natural world, plants have a few...

Editor's picks

Exclusive: “Mitlets” hold potential for mitochondria transfusion

Mitrix Bio believes recently discovered blood components may support transfusion of large quantities of healthy mitochondria from donor to patient. Earlier this year, we brought...

Optimise your body and mind by tackling cell stress

Want to live longer and heathier? Combating cell stress is an important first step on your longevity journey. It's a fast-paced, busy world, and we're...

Crypto – pulling a (Moon) Rabbit out a hat for longevity

Angel Versetti on why it makes sense to look at more experimental solutions for longevity. Earlier this week we brought you part one of our...

Click the globe for translations.

Nurosene Health enters into a non-binding letter of intent with NetraMark for proposed acquisition.

Nurosene Health Inc, a healthtech company focused on building a generation of better brains, is pleased to announce it has entered an arm’s length non-binding term sheet with NetraMark, a private Ontario corporation, to acquire all of its issued and outstanding ‎shares.

Longevity.Technology: Mental health is climbing the longevity agenda, with the idea that true longevity can only be achieved through improving both physical and mental wellbeing becoming firmly embedded. Just this year we have seen investor Christian Angermayer announcing a $120 million fund focused on mental health ventures, iamYiam scaling up its workforce wellbeing platform, the launch of Deep Longevity’s MindAge psychological aging clock and a $550,000 raise for nootropic supplements.

NetraMark was founded in 2016 by Joseph Geraci and Richard Brooks to address current gaps in the pharmaceutical market. The AI and pharmatech company has now developed proprietary solutions for pharmaceutical and biotechnology companies which allow them to leverage their small to large data in order to optimise clinical trials and drug development. NetraMark aims to provide a superior understanding of patient populations and use these insights to develop new drugs and nutraceuticals.

Based in Toronto, Ontario, Nurosene provides individuals with tools and technology that empower them to take control of their mental wellness and their mission is to build the next generation of better, healthier brains by leveraging technological advancements in AI and machine learning.

Nurosene said the non-binding Term Sheet was executed on 9th July, with both parties completing their mutual due diligence investigations on 6th August. It is currently contemplated that all of the required parties will enter into a definitive agreement on or before 15th September 2021 (subject to extension by mutual agreement between the parties) which will contain customary terms and conditions for transactions of this nature.

Nurosene’s CEO, Ranj Bath, commented, “We are looking forward to adding NetraMark’s talented technology team led by Dr Joseph Geraci, whose proprietary machine learning capabilities will evolve and advance Nurosene’s mission for better brain health.

“Based on NetraMark’s powerful data analysis and machine learning capabilities, NetraAI will power the Nuro app, which will not only extract extensive data and research but interpret that data quickly, providing a predictive component for our community’s health and wellness. These insights will be invaluable in supporting Nurosene to continue designing precision solutions, such as drug development, to address mental health challenges and other complex disorders [1].”

Joseph Geraci, PhD, Founder and CEO of NetraMark added, “Nurosene provides a platform and team that we can leverage to further market and transform our proprietary technology. Together we want to build a future for health and wellness that will advance precision medicine and drug development with the goal to develop new and personalized preventative therapeutics.

“By building upon the established AI and data-driven techniques of NetraMark’s products, we can effectively accelerate Nurosene’s mission to improve mental wellness by evaluating and predicting optimal treatments and therapeutic formulations in collaboration with their proprietary mobile application [1].”

[1] https://www.newswire.ca/news-releases/nurosene-health-inc-enters-into-a-non-binding-letter-of-intent-with-netramark-corp-for-proposed-acquisition-849449574.html

Image courtesy of NetraMark
Eleanor Garth
Deputy Editor Now a science and medicine journalist, Eleanor worked as a consultant for university spin-out companies and provided research support at Imperial College London and various London hospitals in a former life.

Most popular

New supplement slows aging and promotes weight loss

Sugar-proof your way to a longer life. Reducing AGEs to slow aging and increase weight loss – how one supplement is fighting the war...

An antiaging supplement that also reduces appetite?

One for the AGEs: Juvify signs IP licensing deal with Buck Institute for GLYLO antiaging supplement that aims to reduce glycation. A researcher at the...

Resveratrol – the small molecule with big antiaging ideas

When it comes to antiaging molecules, we can learn a thing or two from plants. As so often in natural world, plants have a few...

Tree of Longevity – understanding how supplements work

Pathways? Hallmarks? Biomarkers? Understanding the longevity supplements lingo can help you make better choices for your healthspan. Longevity supplements differ from other 'generic supplements' as...

Related articles

Crypto – pulling a (Moon) Rabbit out a hat for longevity

Angel Versetti on why it makes sense to look at more experimental solutions for longevity. Earlier this week we brought you part one of our...

New webinar will explore the opportunity of ovarian longevity

What does delaying menopause mean in terms of investment activity, societal change and the technologies that will reshape the lives of multiple millions of...

Buck Institute awarded $12.7m to join senescence network

NIH award to join SenNet, the Cellular Senescence Network, will enable Buck scientists to identify and characterise senescent cells – recognised as a driver...

Michael Antonov: longevity is all about tackling true unknowns

The Co-founder of Formic Ventures is using logic and innovation to drive the longevity sector forward. Michael Antonov is a serial entrepreneur and philanthropist who...

Deep learning platform seeks near-term indications of age-related diseases

Arrive co-founder talks combining aging cell biology, drug screening and deep learning technology in the quest to discover novel antiaging targets. Silicon Valley and Singapore-based...